Shwu-Huey Liu

A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-based Chemotherapy in Patients with Advanced Colorectal Cancer

Shivaani Kummar, Mehmet Sitki Copur, Michal G. Rose et al. · Clinical Colorectal Cancer · 2011 · 112 citations

Medicine, Oncology, Pharmacology +11

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment

Wing Lam, Zaoli Jiang, Fulan Guan et al. · Scientific Reports · 2015 · 111 citations · Full text

Life Sciences, Oncology, Pharmacology +16

A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906

Robert D. Tilton, Anthony Paiva, Jing-Qu Guan et al. · Chinese Medicine · 2010 · 100 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.

Yun Yen, Samuel So, Michal G. Rose et al. · PubMed · 2009 · 73 citations

Medicine, Oncology, Pharmacology +16

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

Chun A. Changou, Her-Shyong Shiah, Li‐Tzong Chen et al. · The Oncologist · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17